Baldessarini, Ross J. MD1,†; Hennen, John PhD1
1Department of Psychiatry and Neuroscience Program, Harvard Medical School, Bipolar & Psychotic Disorders and Psychopharmacology Programs, and International Consortium for Bipolar Disorder Research, McLean Hospital, Belmont, MA.
Supported, in part, by the Bruce J. Anderson Foundation and McLean Private Donors Neuropsychopharmacology Research Fund.
Original manuscript received 27 May 2003; revised manuscript received 30 November 2003, accepted for publication 15 December 2003.
†Correspondence: Ross Baldessarini, MD, Mailman Research Center 306, McLean Hospital, 115 Mill St., Belmont, MA 02478. Email:[email protected]
doi: 10.1080/10673220490425915